AGBL2 and rheumatoid arthritis: In the same model, the second highest probability was found for anti-CCP2 positivity, anti-filaggrin antibody negativity and anti-CEP-1 antibody positivity with 94 % probability of detecting an individual who would develop RA within 3 years.